Novo Nordisk is at the first phase of localization of new generation insulin at its facility in the Kaluga Region.
Novo Nordisk A/S
Company's website: www.novonordisk.com
T: +45 4444 8888
Public company (NVO)
Contact: Lars Rebien Sørensen, CEO
The world’s biggest insulin maker.